CHE vs SYRE

Comparison between Chemed Corp (CHE, Company) and Spyre Therapeutics Inc (SYRE, Company).

Both CHE and SYRE are from the Healthcare sector.

5-Year PerformanceCHE has outperformed SYRE, delivering a return of -2.4% compared to -13.3%

CHE vs SYRE - Performance Comparison

Log

Key Characteristics

Financial metrics and valuation ratios

Metric	CHE(COMPANY)	SYRE(COMPANY)
Market Cap	$5.94B	$5.92B
Max Drawdown	54.57%	99.11%
Sharpe Ratio	-0.75	2.43
5Y Beta	0.27	1.75
Industry	Medical Care Facilities	Biotechnology
P/E Ratio	24.38	-30.42
Forward P/E	18.25	N/A
PEG Ratio	1.83	N/A
Dividend Yield	0.53%	N/A
5Y Dividends CAGR	16.35%	N/A
5Y EPS CAGR	7.17%	-2.15%
Debt to Equity	10.75%	0.00%
Free Cash Flow Yield	6.35%	-3.14%
P/S Ratio	2.33	650.22
P/B Ratio	6.91	12.66

Market Cap

Winner

CHE

$5.94B

SYRE

$5.92B

Max Drawdown

Winner

CHE

54.57%

SYRE

99.11%

Sharpe Ratio

CHE

-0.75

Winner

SYRE

2.43

5Y Beta

Winner

CHE

0.27

SYRE

1.75

Industry

CHE

Medical Care Facilities

SYRE

Biotechnology

P/E Ratio

CHE

24.38

Winner

SYRE

-30.42

Forward P/E

CHE

18.25

SYRE

N/A

PEG Ratio

CHE

1.83

SYRE

N/A

Dividend Yield

CHE

0.53%

SYRE

N/A

5Y Dividends CAGR

CHE

16.35%

SYRE

N/A

5Y EPS CAGR

Winner

CHE

7.17%

SYRE

-2.15%

Debt to Equity

CHE

10.75%

Winner

SYRE

0.00%

Free Cash Flow Yield

Winner

CHE

6.35%

SYRE

-3.14%

P/S Ratio

Winner

CHE

2.33

SYRE

650.22

P/B Ratio

Winner

CHE

6.91

SYRE

12.66

CHE vs SYRE - Historical Returns

Returns include dividend reinvestment.

Period	CHE	SYRE
1 month	+0.07%	+7.66%
3 months	+5.11%	+99.93%
6 months	-2.23%	+140.30%
1 year	-24.44%	+356.18%
5 years(CAGR)	-2.35%	-13.30%
10 years(CAGR)	+12.83%	-6.27%
Max(CAGR)	+14.27%	-10.30%

CHE

+0.07%

Winner

SYRE

+7.66%

CHE

+5.11%

Winner

SYRE

+99.93%

CHE

-2.23%

Winner

SYRE

+140.30%

CHE

-24.44%

Winner

SYRE

+356.18%

5Y(CAGR)

Winner

CHE

-2.35%

SYRE

-13.30%

10Y(CAGR)

Winner

CHE

+12.83%

SYRE

-6.27%

Max(CAGR)

Winner

CHE

+14.27%

SYRE

-10.30%

CHE vs SYRE - Annual Returns (1999 - 2026)

Returns include dividend reinvestment.

Year	CHE	SYRE
2026	-0.78%	+164.19%
2025	-18.59%	+37.36%
2024	-9.08%	+8.79%
2023	+15.69%	+104.27%
2022	-2.86%	-90.57%
2021	+0.38%	-44.51%
2020	+21.18%	+1.55%
2019	+59.29%	-4.98%
2018	+15.13%	+39.22%
2017	+50.72%	+18.38%
2016	+10.09%	-55.48%
2015	+43.71%	N/A
2014	+42.36%	N/A
2013	+9.35%	N/A
2012	+32.41%	N/A
2011	-19.29%	N/A
2010	+29.93%	N/A
2009	+20.74%	N/A
2008	-26.70%	N/A
2007	+47.57%	N/A
2006	-28.78%	N/A
2005	+51.19%	N/A
2004	+38.29%	N/A
2003	+30.10%	N/A
2002	+5.60%	N/A
2001	+2.17%	N/A
2000	+20.85%	N/A
1999	-1.72%	N/A

CHE vs SYRE Drawdown Comparison

The maximum drawdown for CHE was -54.29%, occurring on Oct 10, 2008. Recovery took 955 trading sessions.

The maximum drawdown for SYRE was -99.11%, occurring on Jun 21, 2023. This drawdown has not yet recovered.

The current CHE drawdown is -34.92%. The current SYRE drawdown is -73.05%.

Rank	CHE	SYRE
#1	-54.29% Jul 12, 2007 - Apr 26, 2011	-99.11% Apr 8, 2016 - Jun 21, 2023
#2	-50.93% Apr 20, 2006 - May 7, 2007	N/A
#3	-42.88% Mar 19, 2024 - Mar 27, 2026	N/A
#4	-35.92% Feb 10, 2004 - Dec 29, 2004	N/A
#5	-32.50% May 10, 2011 - Sep 14, 2012	N/A
#6	-31.11% Jan 18, 2001 - Apr 17, 2002	N/A
#7	-30.63% Feb 19, 2020 - Aug 6, 2020	N/A
#8	-26.54% Jan 25, 2021 - Apr 11, 2023	N/A
#9	-24.18% May 14, 2002 - May 30, 2003	N/A
#10	-21.87% May 2, 2013 - Feb 18, 2014	N/A
#11	-20.43% Dec 1, 2015 - Dec 15, 2016	N/A
#12	-20.03% May 18, 2018 - May 6, 2019	N/A
#13	-16.23% Jul 8, 2003 - Dec 19, 2003	N/A
#14	-16.13% Nov 2, 1999 - Dec 22, 1999	N/A
#15	-15.51% Aug 7, 2015 - Oct 27, 2015	N/A

Correlation

Correlation between CHE and SYRE is -0.51 which considered as a moderate negative correlation - the stocks show some tendency to move in opposite directions.

-0.51

-101